Export this record

Export record to excel

File type to download

Beta version

Select record 1

ArticlesPeer ReviewedFull Text

Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial

Author / Creator:Pinto, Carmine, MD ; Zucali, Paolo Andrea, MD ; Pagano, Maria, MD ; Grosso, Federica, MD ; Pasello, Giulia, MD ; Garassino, Marina Chiara, MD ; Tiseo, Marcello, MD ; Soto Parra, Hector, MD ; Grossi, Francesco, MD ; Cappuzzo, Federico, MD ; de Marinis, Filippo, MD ; Pedrazzoli, Paolo, MD ; Bonomi, Maria, MD ; Gianoncelli, Letizia, MD ; Perrino, Matteo, MD ; Santoro, Armando, MD ; Zanelli, Francesca, MD ; Bonelli, Candida, MD ; Maconi, Antonio, MD ; Frega, Stefano, MD ; Gervasi, Erika, MD ; Boni, Luca, MD ; Ceresoli, Giovanni Luca, MD

Publisher:England: Elsevier Ltd

Journal title:The lancet oncology, 2021-10, Vol.22 (10), p.1438-1447

View online as a Library member

Export record to excel

Export this record

Export record to excel

Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial

Refine your search